Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Mark A. Goldsmith, M.D., PhD$5.8B
Market Cap • 25/04/20242014
(há 10 anos)
2020
(4 years ago)
NASDAQ
Listagem
Redwood City
Sede • California246
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
RVMDSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.